Rima Al-awar, Pharmacology & Toxicology, University of Toronto and Ontario Institute for Cancer Research (OICR), Canada.
“The Optimization and Characterization of WDR5 Binders”
Shaomeng Wang, Pharmacology and Medicinal Chemistry,
University of Michigan, USA
Jean-François Couture, Biochemistry, Microbiology and Immunology, University of Ottawa, Canada
Michael Cosgrove, Biochemistry and Molecular Biology, State University of New York Upstate Medical University, USA
"Targeting the Win motif-WDR5 interaction in SET1/MLL family histone methyltransferases"
Kehao Zhao, Novartis, USA
Mathieu Lupien, Medical Biophysics,University of Toronto, Canada
Ingo Hartung, Drug Discovery, Pharmaceuticals, Bayer, Germany
“Identification of Chemical Probes for Protein Methyltransferases: SMYD2 and Beyond”
Benjamin Garcia, Biochemistry and Biophysics, University of Pennsylvania School of Medicine. USA
Jocelyn Côté, Cellular and Molecular Medicine, University of Ottawa, Canada
Paul Delgado-Olguín, Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, Canada.
“Repressive Histone Methyltransferases as Regulators of Cardiovascular Development and Disease”
Jean-Claude Guillemot, AFMB Polytech, Marseille, France
Dafydd Owen, Pfizer, USA